Israeli firm wants to cure diabetes with liver cells
The biotech company Orgenesis of Israel has developed a cellular therapy that could restore the body’s own production of insulin for diabetes patients using their own liver cells. The company hopes to initiate clinical trials in the next 18 months.
BY LONNI LYNGE
STOCKHOLM
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
It is becoming more difficult for Novo to make money
For abonnenter
